Table 1 Patient characteristics in the complete study population (n = 177) and in the participants with AUDIT scores available (n = 60). The table presents the groups by age, gender, duration of stay, body mass index, diagnoses and phosphatidylethanol (PEth) concentrations

Men n (%)

84 (47.5)

29 (48.3)

Women n (%)

93 (52.5)

31 (51.7)

Body mass index, kg/m², mean (SD)

25.1 (5.0)

25.5 (4.8)

Age, years, mean (SD)

38.1 (16.0)

39.50 (16.7)

Men, age, mean (SD)

39.9 (16.9)

39.7 (17.6)

Women, age, mean (SD)

36.5 (15.0)

39.2 (16.0)

Duration of stay in days, mean (SD)

7.7 (5.7)

6.6 (4.3)

 F10-19 Mental and behavioral disorders due to psychoactive substance use, n (%)

23 (13)

7 (11.7)

 F20-29 Schizophrenia, schizotypal and delusional disorders n, (%)

9 (5.1)

4 (6.7)

 F30-39 Mood [affective] disorders, n (%)

59 (33.3)

23 (38.3)

 F40-48 Neurotic, stress-related and somatoform disorders, n (%)

34 (19.2)

13 (21.7)

 F50-59 Behavioral syndromes associated with physiological disturbances and physical factors, n (%)

1 (0.6)

0

 F60-69 Disorders of adult personality and behavior, n (%)

26 (14.7)

8 (13.3)

 Other disorders, n (%)

25 (14.1)

5 (8.3)

 Alcohol diagnosis (F10.0-10.9), n (%)^a

27 (15.3)

10 (16.7)

 PEth concentration > 0.03 μmol/l, n (%)

81 (45.8)

31 (51.7)